Optibrium Launches Online Community for Drug Optimisation
News Nov 23, 2009
The Optibrium community will also provide a forum for the wider drug discovery community to discuss approaches to drug optimisation and share ideas and best practices aimed at improving the productivity of drug discovery.
The Optibrium community site includes interactive forums covering topics such as drug design and optimisation, as well as the application of StarDrop to challenges in drug discovery projects. Articles and presentations by the Optibrium team and the wider community are accessible to everyone and available for comment by community members. Additional predictive QSAR models and scripts that extend the functionality of StarDrop can also be downloaded. Furthermore, access to technical support and FAQs through the community site will bring the Optibrium team even closer to our user base and allow StarDrop users to learn from others’ experience.
Ed Champness, CSO of Optibrium, commented “We are excited by this latest development which will bring together our hundreds of users worldwide and help them to get the most out of StarDrop. We also believe that this will be a stimulating environment for discussion of wider issues and solutions to the challenges of quickly and efficiently discovering new drug candidates.”
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018